Repurposed Oral Ribavirin for Respiratory Virus Infections Requires Pharmacokinetic-pharmacodynamic Dose Optimization

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

1 Citation (Scopus)

160 Downloads (Pure)

Original language	English
Pages (from-to)	1258
Number of pages	1
Journal	Clinical Infectious Diseases
Volume	70
Issue number	6
Early online date	4-Jul-2019
DOIs	https://doi.org/10.1093/cid/ciz593
Publication status	Published - 3-Mar-2020

Access to Document

@article{57f7faff9cfd408380464db1727f6110,

title = "Repurposed Oral Ribavirin for Respiratory Virus Infections Requires Pharmacokinetic-pharmacodynamic Dose Optimization",

author = "{de Zwart}, {Auke E S} and Annelies Riezebos-Brilman and Kerstjens, {Huib A M} and Verschuuren, {Erik A M} and Alffenaar, {Jan-Willem C}",

year = "2020",

month = mar,

day = "3",

doi = "10.1093/cid/ciz593",

language = "English",

volume = "70",

pages = "1258",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Repurposed Oral Ribavirin for Respiratory Virus Infections Requires Pharmacokinetic-pharmacodynamic Dose Optimization

AU - de Zwart, Auke E S

AU - Riezebos-Brilman, Annelies

AU - Kerstjens, Huib A M

AU - Verschuuren, Erik A M

AU - Alffenaar, Jan-Willem C

PY - 2020/3/3

Y1 - 2020/3/3

U2 - 10.1093/cid/ciz593

DO - 10.1093/cid/ciz593

M3 - Letter

C2 - 31271195

SN - 1058-4838

VL - 70

SP - 1258

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 6

ER -